HEALY JAMES (CIK 1245624) reported 6 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2025-09-18). Recent activity: Sell YMAB (31,603 shares), Sell YMAB (25,080 shares), Sell YMAB (2.2M shares), Buy YMAB (25,080 shares), Buy NTRA (142 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-09-18 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Sell | 31,603 | $271,786 |
| 2025-09-18 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Sell | 25,080 | $0 |
| 2025-09-18 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Sell | 2.2M | $18.9M |
| 2025-07-02 | Y-mAbs Therapeutics, Inc. (YMAB) | Director | Buy | 25,080 | $0 |
| 2025-04-29 | Natera, Inc. (NTRA) | Director | Buy | 142 | $0 |
| 2025-02-04 | Natera, Inc. (NTRA) | Director | Buy | 114 | $0 |
Source: SEC Form 4 filings · as of 2025-09-18